Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus-Reference-Cited by-同舟云学术

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus

Published:2015-08 Issue:2 Volume:170 Page:322-329.e4
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Lewis Eldrin F.,Claggett Brian,Parfrey Patrick S.,Burdmann Emmanuel A.,McMurray John J.V.,Solomon Scott D.,Levey Andrew S.,Ivanovich Peter,Eckardt Kai-Uwe,Kewalramani Reshma,Toto Robert,Pfeffer Marc A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. United States Renal Data System Annual Data Report 2013: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States;USRDS,2013

2. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes;Cowie;N Engl J Med,1989

3. Incidence and predictors of end stage renal disease among low-income blacks and whites;Lipworth;PLoS One,2012

4. Chronic kidney disease in United States Hispanics: a growing public health problem;Lora;Ethn Dis,2009

5. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension;McClellan;Am J Kidney Dis,1988

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions for fatigue in people with kidney failure requiring dialysis;Cochrane Database of Systematic Reviews;2023-08-31

2. Impact of end stage renal disease on the clinical outcomes of diabetics admitted for heart failure: Analysis of national inpatient sample;Journal of Cardiovascular and Thoracic Research;2023-03-16

3. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

4. Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease;Diabetes/Metabolism Research and Reviews;2022-07-11

5. Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event Analysis;Clinical Pharmacokinetics;2021-11-13